Abstract
A structure-activity relationship (SAR) dataset was generated for a set of acetylcholinesterase inhibitors using Adaboost and physicochemical parameters. After calculation, it is found that the ACC of SAR model is 99.51 by using 10-fold cross-validation test, while 99.35% for independent test set. Based on the SAR prediction model, bakuchiol is predicted to be an acetylcholinesterase inhibitor. Fluorescence was used to investigate the binding between bakuchiol and acetylcholinesterase, which can provide valuable qualitative and quantitative information about the interaction between acetylcholinesterase and bakuchiol.
Keywords: Molecular descriptors, acetylcholinesterase, bakuchiol, Adaboost.
Graphical Abstract
Current Bioinformatics
Title:Prediction of an Interaction between Bakuchiol and Acetylcholinesterase using Adaboost
Volume: 11 Issue: 1
Author(s): Can Zhang, Xueyuan Wang, Lei Gu, Li Jiang, Qiang Su, Manman Zhao, Linfeng Zheng, Ling Tang, Fuxue Chen and Bing Niu
Affiliation:
Keywords: Molecular descriptors, acetylcholinesterase, bakuchiol, Adaboost.
Abstract: A structure-activity relationship (SAR) dataset was generated for a set of acetylcholinesterase inhibitors using Adaboost and physicochemical parameters. After calculation, it is found that the ACC of SAR model is 99.51 by using 10-fold cross-validation test, while 99.35% for independent test set. Based on the SAR prediction model, bakuchiol is predicted to be an acetylcholinesterase inhibitor. Fluorescence was used to investigate the binding between bakuchiol and acetylcholinesterase, which can provide valuable qualitative and quantitative information about the interaction between acetylcholinesterase and bakuchiol.
Export Options
About this article
Cite this article as:
Zhang Can, Wang Xueyuan, Gu Lei, Jiang Li, Su Qiang, Zhao Manman, Zheng Linfeng, Tang Ling, Chen Fuxue and Niu Bing, Prediction of an Interaction between Bakuchiol and Acetylcholinesterase using Adaboost, Current Bioinformatics 2016; 11 (1) . https://dx.doi.org/10.2174/1574893611666151119220248
DOI https://dx.doi.org/10.2174/1574893611666151119220248 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
GABAA Receptors in Normal Development and Seizures: Friends or Foes?
Current Neuropharmacology Phentermine and Topiramate Extended-Release for the Obesity: New Kids on the Block
Recent Patents on Cardiovascular Drug Discovery Glutathione-Related Factors and Oxidative Stress in Autism, A Review
Current Medicinal Chemistry Annual Trends in Use of Periconceptional Folic Acid and Birth Prevalence of Major Congenital Malformations
Current Drug Safety Adult Stem Cell Application in Spinal Cord Injury
Current Drug Targets Functional Annotation of Genes Overlapping Copy Number Variants in Autistic Patients: Focus on Axon Pathfinding
Current Genomics Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Current Pharmaceutical Design FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects
Current Radiopharmaceuticals Release of Adenosine and ATP During Ischemia and Epilepsy
Current Neuropharmacology Recent Advances in the Treatment of Neurogenic Erectile Dysfunction
Recent Patents on CNS Drug Discovery (Discontinued) Association Between Seizures and Diabetes Mellitus: A Comprehensive Review of Literature
Current Diabetes Reviews Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives
Central Nervous System Agents in Medicinal Chemistry Neurological Disorders of Purine and Pyrimidine Metabolism
Current Topics in Medicinal Chemistry Recent Highlights on Molecular Hybrids Potentially Useful in Central Nervous System Disorders
Mini-Reviews in Medicinal Chemistry Synthesis and DPPH Radical Scavenging Activity of 5-Arylidene-N,Ndimethylbarbiturates
Medicinal Chemistry Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume I)
CNS & Neurological Disorders - Drug Targets Interactions between Ketamine and Magnesium for the Treatment of Pain: Current State of the Art
CNS & Neurological Disorders - Drug Targets Design, Synthesis and Anticonvulsant Activity Evaluation of 7-Substituted –[1,2,4]-Triazolo[4,3-f]Pyrimidine Derivatives
Medicinal Chemistry How to Find Candidate Drug-targets for Antiepileptogenic Therapy?
Current Neuropharmacology Winning a Won Game: Caffeine Panacea for Obesity Syndemic
Current Neuropharmacology